Oppenheimer lowered the firm’s price target on Cogent (CCOI) to $30 from $40 and keeps an Outperform rating on the shares. The firm says results missed but not as poorly as recent quarters. Oppenheimer thinks the stock is oversold, but is very risky. Near-term catalysts are potential datacenter sales and debt refinancing, which should help the balance sheet.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CCOI:
- Cogent price target lowered to $22 from $25 at Citi
- Cogent Communications Balances Margin Gains With Debt Risks
- Cogent price target lowered to $21 from $27 at UBS
- Cogent’s Use of ARIN RPKI Boosts Routing Security but Adds New Systemic Risks, Analyst Warns
- Cogent reports Q4 EPS (64c), consensus ($1.09)